BIOMAR GROUP A/S (BIOMAR.CO)

133.50DKK +0.60% (+0.80)

Over 1M: +21.4%

2026-08-25

110 120 130

28 Jul 31 Jul 5 Aug 10 Aug 13 Aug 18 Aug 21 Aug

Multiples & size

2025-12-31

Market cap 13.34Mp

P/E TTM 0.018×p

EV/EBITDA -0.24×p

EV/EBIT -0.24×p

P/B 0.0042×p

P/S TTM 0.00081×p

EPS TTM 7553.17

FCF yield 9801.9%p

Dividend yield 5388.0%p

Revenue growth -0.49%

Operating margin 6.8%

Net margin 4.6%

FCF margin 7.9%

ROIC 30.6%

Payout 95.2%

52-week range

63 trading days

105.00 133.50 (100%) 133.50

Figures as at 2025-12-31, reported in DKK. The newest fact in the filings is dated 2026-01-01, 237 days ago. Nothing on this page is advice.

How it scores

Five questions, each answered by the measures under it. Every figure is the company's own; the bar beside it is where that figure sits among the companies read here — the top fifth, the bottom fifth, or somewhere between. Not among all listed companies, and for a valuation multiple the low end is the good end.

Quality

How much of the revenue is really kept — and what did it take to earn it?

4.7

SBC / sales 0.0%

ROIC 30.6%

OE margin 7.9%

Oper. margin 6.8%

Adj. EBITDA margin 6.8%

Valuation

What does the price ask for what the company earns, owns and pays out?

0.5

EV/EBIT -0.24×

EV/OE -0.21×

Resilience

Can the balance sheet absorb a bad year?

4.1

ND/EBITDA -1.0

Interest cover 4.4×

Current ratio 0.9×

Growth

Is the business getting bigger, and is it getting more profitable?

1.0

Sales/sh Y/Y -0.49%

A measure absent from a block could not be computed from this company's filings. It is left out rather than scored as though it were bad, and the dimension is averaged over what remains. A score is measured against a fixed scale this model states; the bar is measured against the other companies, so the two can disagree — and where they do, that disagreement is the more interesting figure.

The ratios

The figures themselves rather than their scores — what somebody looking up BIOMAR.CO on one particular measure came for.

Ratio	Value
cash operating margin	6.85
current ratio	0.9
current ratio reported	0.9
ev ebit	-0.24
ev owner earnings	-0.21
ev sales	-0.02
fcf margin	7.91
interest cover	4.4
operating margin	6.85
owner earnings margin	7.91
revenue growth	-0.49
revenue growth per share	-0.49
roic	30.62
rule of 40	6.35
sbc pct revenue	0.0

The figures, and where each came from

This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.

Figure	Value	XBRL tag	As at
capex	260,000,000	`PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities`	2025-12-31
cash	632,000,000	`CashAndCashEquivalents`	2026-01-01
current assets	6,739,000,000	`CurrentAssets`	2026-01-01
current liabilities	7,460,000,000	`CurrentLiabilities`	2026-01-01
equity	3,206,000,000	`EquityAttributableToOwnersOfParent`	2026-01-01
interest expense	257,000,000	`FinanceCosts`	2025-12-31
ocf	1,568,000,000	`CashFlowsFromUsedInOperatingActivities`	2025-12-31
revenue	16,534,000,000	`Revenue`	2025-12-31

What to be careful about

revenue is annual, not TTM
operating income is annual, not TTM
no current stock compensation tagged; treated as zero, so owner earnings are overstated
no usable diluted share count, so growth is measured on total revenue rather than per share; a company issuing shares to fund that growth reads better than it is
gross profit last tagged 2021-12-31 and no cost of sales line to rebuild it from; dropped from durability
no forward EPS estimate; growth rests on filings only. Analyst consensus is not published in XBRL, so it has to be fetched from a data provider or set by hand in overrides.yaml as `eps_growth_2y`

See it scored yourself

The dashboard puts BIOMAR.CO beside other companies and lets you change what counts: the weight of each dimension, the value that earns a ten, and which of the 61 measures are included at all.